Follow the people · Insider

CP

Christopher Peetz

Insider · Chief Executive Officer · MIRM

Christopher Peetz files insider transactions with the SEC as a chief executive officer of Mirum Pharmaceuticals (MIRM). We hold 8 disclosed purchases and sales filed since 6 May 2015, 3 of them in the last 90 days.

  • Files forMIRM
  • Disclosed buys and sells8 in all, 3 in the last 90 days
  • Last disclosure3 September 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 6 September 20191 September 2026Chief Executive Officer · Mirum Pharmaceuticals (MIRM)107 Form 4 lines · source: SEC Form 4
  • Filed 15 July 202615 July 2026Director · Arcutis Biotherapeutics (ARQT)3 Form 4 lines · source: SEC Form 4
  • Filed 20 April 201820 May 2024Director · Alpine Immune Sciences (ALPN)17 Form 4 lines · source: SEC Form 4
  • Filed 6 May 20151 November 2016Chief Financial Officer · Tobira Therapeutics (TBRA)8 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.